Discovery and characterization of a pan-betacoronavirus S2-binding antibody

发现并鉴定了一种泛β冠状病毒S2结合抗体

阅读:10
作者:Nicole V Johnson ,Steven C Wall ,Kevin J Kramer ,Clinton M Holt ,Sivakumar Periasamy ,Simone I Richardson ,Nelia P Manamela ,Naveenchandra Suryadevara ,Emanuele Andreano ,Ida Paciello ,Giulio Pierleoni ,Giulia Piccini ,Ying Huang ,Pan Ge ,James D Allen ,Naoko Uno ,Andrea R Shiakolas ,Kelsey A Pilewski ,Rachel S Nargi ,Rachel E Sutton ,Alexandria A Abu-Shmais ,Robert Parks ,Barton F Haynes ,Robert H Carnahan ,James E Crowe Jr ,Emanuele Montomoli ,Rino Rappuoli ,Alexander Bukreyev ,Ted M Ross ,Giuseppe A Sautto ,Jason S McLellan ,Ivelin S Georgiev

Abstract

The continued emergence of deadly human coronaviruses from animal reservoirs highlights the need for pan-coronavirus interventions for effective pandemic preparedness. Here, using linking B cell receptor to antigen specificity through sequencing (LIBRA-seq), we report a panel of 50 coronavirus antibodies isolated from human B cells. Of these, 54043-5 was shown to bind the S2 subunit of spike proteins from alpha-, beta-, and deltacoronaviruses. A cryoelectron microscopy (cryo-EM) structure of 54043-5 bound to the prefusion S2 subunit of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike defined an epitope at the apex of S2 that is highly conserved among betacoronaviruses. Although non-neutralizing, 54043-5 induced Fc-dependent antiviral responses in vitro, including antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP). In murine SARS-CoV-2 challenge studies, protection against disease was observed after introduction of Leu234Ala, Leu235Ala, and Pro329Gly (LALA-PG) substitutions in the Fc region of 54043-5. Together, these data provide new insights into the protective mechanisms of non-neutralizing antibodies and define a broadly conserved epitope within the S2 subunit.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。